University of Michigan | Strategic Alliance Partners

Connect with us:

Latest from University of Michigan

Dr. Phillips on p53 Mutations in MCL

July 20, 2022

Video

Tycel Jovelle Phillips, MD, discusses the role of p53 mutations in the outcomes of patients with mantle cell lymphoma.

ModraDoc006 Plus Ritonavir Shows Favorable Safety, Comparable Efficacy to IV Docetaxel in mCRPC

July 14, 2022

Article

The combination of ModraDoc006—a novel, oral tablet formulation of docetaxel—and ritonavir produced comparable response rates and radiographic progression-free survival to that achieved with intravenous docetaxel in patients with metastatic castration-resistant prostate cancer.

OncLive Honors 13 Cancer Care Pioneers

June 02, 2022

Article

For the 10th consecutive year, OncLive® is honored to recognize oncology leaders whose innovations have contributed to immeasurable improvements in outcomes for countless patients.

Dr. Vaishampayan on the Rationale of the PROBE Trial in RCC

June 01, 2022

Video

Ulka Nitin Vaishampayan, MBBS, discusses the rationale of the phase 3 PROBE trial in advanced renal cell carcinoma.

Dr. Vaishampayan on the Design of the PROBE Trial in RCC

May 13, 2022

Video

Ulka Nitin Vaishampayan, MBBS, discusses the design of the phase 3 PROBE trial in advanced renal cell carcinoma.

PROBE Trial in Progress to Understand Potential Benefits of Cytoreductive Nephrectomy in Metastatic RCC

April 20, 2022

Article

Ulka Nitin Vaishampayan, MBBS, discusses the intent of the PROBE trial, as well as updates regarding the KEYNOTE-564 trial and novel agents in kidney cancer treatment.

Dr. Vaishampayan on the PROBE Trial in Advanced RCC

April 05, 2022

Video

Ulka Nitin Vaishampayan, MBBS, discusses the intent of the phase 3 PROBE trial in advanced renal cell carcinoma.

Dr. Kim on Optimizing Individualized Treatment in Cancer Care

April 04, 2022

Video

Michelle Miran Kim, MD, discusses optimizing individualized treatment in cancer care.

Dr. Palmbos on the Utilization of Nivolumab Following Cystectomy in Muscle-Invasive Bladder Cancer

February 16, 2022

Video

Phillip Palmbos, MD, PhD, discusses the utilization of adjuvant nivolumab following cystectomy in high-risk, muscle-invasive bladder cancer.

Dr. Phillips on the Current Role of Ibrutinib in MCL

February 03, 2022

Video

Tycel Jovelle Phillips, MD, discusses the current role of ibrutinib in mantle cell lymphoma.

Dr. Phillips Discusses Ongoing Research With BTK Inhibitors in MCL

January 19, 2022

Video

Tycel Jovelle Phillips, MD, discusses ongoing research with BTK inhibitors in mantle cell lymphoma.

Dr. Yentz on Translating Data to Real-World Clinical Practice in RCC

January 18, 2022

Video

Sarah Elizabeth Yentz, MD, discusses translating data to real-world clinical practice in renal cell carcinoma.

Dr. Phillips Discusses Ongoing Trials in MCL

January 17, 2022

Video

Tycel Jovelle Phillips, MD, discusses ongoing trials in mantle cell lymphoma.

Dr. Phillips on Considering Age During Treatment Selection With BTK Inhibitors in MCL

January 10, 2022

Video

Tycel Jovelle Phillips, MD, discusses the importance of considering age during treatment selection for BTK inhibitors in mantle cell lymphoma.

Dr. Phillips on Navigating Treatment Selection With BTK Inhibitors in MCL

January 03, 2022

Video

Tycel Jovelle Phillips, MD, discusses navigating treatment selection with BTK inhibitors in mantle cell lymphoma.

Phillips Reflects on Lessons Learned With BTK Inhibitors in MCL

December 23, 2021

Podcast

Dr Phillips discusses the utility of ibrutinib, acalabrutinib, and zanubrutinib in mantle cell lymphoma, the impact of long-term follow-up data with ibrutinib, and findings from the phase 3 SYMPATICO trial that could shake up the treatment paradigm.

Dr. Qin on Treatment Considerations for Immunotherapy in NSCLC

December 06, 2021

Video

Angel Qin, MD, discusses treatment considerations for immunotherapy in patients with newly diagnosed non–small cell lung cancer.

Dr. Qin on Selecting Single-Agent Immunotherapy or Chemoimmunotherapy in NSCLC

December 03, 2021

Video

Angel Qin, MD, discusses selecting between single-agent immunotherapy or combination chemoimmunotherapy in non–small cell lung cancer.

Dr. Vaishampayan on the Future Directions for Second-Line Treatment in Urothelial Cancer

November 23, 2021

Video

Ulka Nitin Vaishampayan, MBBS, discusses future directions for second-line treatment in urothelial cancer.

Dr. Palmbos on Remaining Questions in Metastatic Urothelial Carcinoma

November 22, 2021

Video

Phillip L. Palmbos, MD, PhD, discusses remaining questions in metastatic urothelial carcinoma.